Anixa Biosciences Inc (NASDAQ:ANIX)
| 4.33 Delayed Data As of Mar 24 |  +0.05 / +1.16%Today’s Change | 2.50 Today|||52-Week Range 6.25 | +1.88% Year-to-Date |
Latest ANIX News | Press Releases
No recent news for Anixa Biosciences Inc.
Today’s Trading
| Previous close | 4.31 |
| Today’s open | 4.26 |
| Day’s range | 4.11 - 4.39 |
| Volume | 38,361 |
| Average volume (3 months) | 50,726 |
| Market cap | $134.8M |
Data as of 3:59pm ET, 03/24/2023
Growth & Valuation
| Earnings growth (last year) | +1.26% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 4.64 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NKTRNektar Therapeutics | -0.03 | -3.38% |
| ARAVAravive Inc | +0.03 | +1.32% |
| CRMDCorMedix Inc | +0.12 | +3.65% |
| CUECue Biopharma Inc | +0.02 | +0.61% |
Data as of 4:00pm ET, 03/24/2023
Financials
| Last reporting date | March 27, 2023 |
| EPS forecast (this quarter) | -$0.08 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$13.6M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Jose, California |
Forecasts
